Wachsman D E, Kavaler J P, Sugár I P, Schachter E N, Gonsiorek W, Maayani S
Department of Anesthesiology, Mount Sinai School of Medicine, City University of New York, New York, USA.
J Pharmacol Exp Ther. 1997 Jan;280(1):332-45.
Activation of beta-2 adrenoceptors (BAR) in smooth muscle preparations is associated with a rapid, reversible and incomplete receptor desensitization, resulting in a steady-state relaxation response to BAR agonists. Based on results from cell culture studies, we hypothesize that, in the isolated guinea pig trachea, this steady state is a result of a concurrent resensitization of desensitizing BAR. In tracheal segments maintained at mechanical tone (4-6 g), isoproterenol (ISO) and the partial BAR agonist salbutamol (SALB) elicited a monotonic, rapid (1-3 min) and reproducible relaxation response that could be maintained for up to 45 min and was completely reversed by propranolol. Similarly, tissues preconstricted with 0.1 microM carbachol (CARB) responded with a sustained relaxation response to ISO. In contrast, in tissues preconstricted with 0.3 to 10 microM CARB or with 75 mM KCl, the relaxation elicited by ISO was followed by a slow (20-30 min) and partial restoration of muscle tone ("fade"). The relaxation and fade were observed when CARB-constricted tissues were relaxed with SALB (0.2 or 10 microM) or 10 microM salmeterol. No response to SALB was observed when tissues were preconstricted with KCl. The fade met criteria for its classification as a homologous desensitization of the relaxation response at the BAR level. In desensitized washed tissues, a complete recovery of the original relaxation response could be detected within 60 min of drug removal. A propranolol- and ICI 118-551-sensitive steady state was achieved 30 to 35 min after the addition of BAR agonists to the isolated tissues. A three-compartment phenomenological kinetic model accurately described the observed data, defining one steady-state and three rate constants, describing relaxation (k1), desensitization (k2) and resensitization (k3). The values of k2 and k3 for the response to SALB and to salmeterol were significantly larger than those observed for ISO. In the presence of KCl, the values of k2 and k3 for the response to ISO were indistinguishable from those measured in the presence of CARB. Given the parameters defined by our model, we propose that desensitization and resensitization of BAR in the isolated guinea pig trachea are distinct concurrent processes whose net result actively maintains a sustained partial relaxation response to ISO, SALB or salmeterol. The component of resensitization in the presence of agonist may account for the clinical efficacy of inhaled BAR agonists.
平滑肌制剂中β2肾上腺素能受体(BAR)的激活与快速、可逆且不完全的受体脱敏相关,导致对BAR激动剂产生稳态舒张反应。基于细胞培养研究结果,我们推测,在分离的豚鼠气管中,这种稳态是脱敏BAR同时再敏化的结果。在维持机械张力(4 - 6克)的气管节段中,异丙肾上腺素(ISO)和部分BAR激动剂沙丁胺醇(SALB)引发单调、快速(1 - 3分钟)且可重复的舒张反应,该反应可持续长达45分钟,且可被普萘洛尔完全逆转。同样,预先用0.1微摩尔卡巴胆碱(CARB)预收缩的组织对ISO产生持续的舒张反应。相比之下,在预先用0.3至10微摩尔CARB或75毫摩尔氯化钾预收缩的组织中,ISO引发的舒张之后是肌肉张力的缓慢(20 - 30分钟)且部分恢复(“消退”)。当用SALB(0.2或10微摩尔)或10微摩尔沙美特罗使CARB预收缩的组织舒张时,观察到舒张和消退现象。当用氯化钾预收缩组织时,未观察到对SALB的反应。这种消退符合其作为BAR水平舒张反应同源脱敏的分类标准。在脱敏的冲洗组织中,去除药物后60分钟内可检测到原始舒张反应完全恢复。在向分离组织中加入BAR激动剂后30至35分钟达到普萘洛尔和ICI 118-551敏感的稳态。一个三室现象学动力学模型准确描述了观察到的数据,定义了一个稳态和三个速率常数,分别描述舒张(k1)、脱敏(k2)和再敏化(k3)。对SALB和沙美特罗反应的k2和k3值显著大于对ISO观察到的值。在存在氯化钾的情况下,对ISO反应的k2和k3值与在存在CARB时测量的值无差异。根据我们模型定义的参数,我们提出,在分离的豚鼠气管中,BAR的脱敏和再敏化是不同的并发过程,其净结果积极维持对ISO、SALB或沙美特罗的持续部分舒张反应。激动剂存在时的再敏化成分可能解释吸入性BAR激动剂的临床疗效。